AccuRna (株式会社アキュルナ) is a company developing a drug delivery system (DDS) for nucleic acid therapeutics, both of short chain including ASO, siRNA, miRNA and long chain, mRNA as a therapeutic drug. It aims to deliver a cure to patients suffering from refractory diseases.